Pharmaceutical industry representatives in Washington are scrambling to measure the damage Robert F. Kennedy Jr. might inflict on the FDA.
WASHINGTON — Robert F. Kennedy Jr., President-elect Trump’s nominee for Secretary of Health and Human Services, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback